Surface labeling of Pneumocystis carinii from in vitro culture

J A Radding1, M Y Armstrong, M S Bogucki

  • 1Yale MacArthur Center for Molecular Parasitology, Yale University School of Medicine, New Haven, CT 06510.

The Journal of Protozoology
|January 1, 1989
PubMed

Insights

Researchers identified a key surface glycoprotein (gp120) on Pneumocystis carinii, an opportunistic pathogen causing pneumonia in immunocompromised individuals, including those with HIV/AIDS.

Area of Science:

  • Medical Mycology
  • Immunology
  • Virology

Background:

  • Pneumocystis carinii is an opportunistic pathogen causing fatal pneumonia in immunosuppressed individuals.
  • It is a significant complication in human immunodeficiency virus type 1 (HIV-1) infection, leading to acquired immunodeficiency syndrome (AIDS).
  • Understanding P. carinii's surface components is crucial for developing diagnostic and therapeutic strategies.

Purpose of the Study:

  • To identify and characterize major surface glycoproteins of Pneumocystis carinii.
  • To investigate the role of these glycoproteins in organism adherence.
  • To develop effective purification methods for these surface molecules.

Main Methods:

  • Surface radioiodination of in vitro cultured rat-derived P. carinii trophozoites.
  • Gel chromatography and hydroxyapatite chromatography in sodium dodecyl sulfate for glycoprotein purification.
  • Preliminary characterization of the purified glycoprotein.

Main Results:

  • A major surface glycoprotein, designated gp120, was identified on P. carinii trophozoites.
  • The purified gp120 demonstrated adherent properties, mirroring the intact organism's behavior.
  • Conventional purification methods were ineffective due to irreversible binding; a specialized chromatographic approach was successful.

Conclusions:

  • Pneumocystis carinii possesses a major surface glycoprotein (gp120) involved in adherence.
  • The unique binding properties of gp120 necessitate specific purification techniques.
  • Further characterization of gp120 may offer insights into P. carinii pathogenesis and potential therapeutic targets.

Related Concept Videos